EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Transcriptomic analysis of benznidazole-resistant Trypanosoma cruzi clone reveals nitroreductase I-independent resistance mechanisms

Ana María Mejía-Jaramillo, Hader Ospina-Zapata, Geysson Javier Fernandez iD, Omar Triana-Chávez iD

PLOS ONE · 2025

DOI: 10.1371/journal.pone.0314189 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2025. Verfasst von Ana María Mejía-Jaramillo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Grupo Biología y Control de Enfermedades Infecciosas, BCEI, Universidad de Antioquia, UdeA, Medellín, Colombia, South America. Hauptthemen laut MEDLINE: Nitroimidazoles, Trypanosoma cruzi, Nitroreductases, Protozoan Proteins. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidad de Antioquia UdeA, SGR.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The enzyme nitroreductase I (NTRI) has been implicated as the primary gene responsible for resistance to benznidazole (Bz) and nifurtimox in Trypanosoma cruzi . However, Bz-resistant T. cruzi field isolates carrying the wild-type NTR-I enzyme suggest that additional mechanisms independent of this enzyme may contribute to the resistance phenotype. To investigate these alternative mechanisms, in this paper, we pressured a Trypanosoma cruzi clone with a high Bz concentration over several generations to select Bz-resistant clones. Surprisingly, we found a highly drug-resistant clone carrying a wild-type NTRI. However, the knockout of this gene using CRISPR-Cas9 in the sensitive clone showed that NTRI indeed induces resistance to Bz and supports the idea that the resistant one exhibits mechanisms other than NTRI. To explore these new mechanisms, we performed an RNA-seq analysis, which revealed genes involved in metabolic pathways related to oxidative stress, energy metabolism, membrane transporters, DNA repair, and protein synthesis. Our results support the idea that resistance to benznidazole is a multigenic trait. A Deeper understanding of these genes is essential for developing new drugs to treat Chagas disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NitroimidazolesTrypanosoma cruziNitroreductasesProtozoan ProteinsDrug ResistanceTrypanocidal AgentsGenes, ProtozoanGene Knockout TechniquesRNA-SeqGene Expression RegulationMultigene FamilyInhibitory Concentration 50Parasitic Sensitivity TestsChagas DiseaseHumans

Substanzen

benzonidazoleTrypanocidal AgentsNitroimidazolesNitroreductasesProtozoan Proteins

Autor:innen und Institutionen

  • Grupo Biología y Control de Enfermedades Infecciosas, BCEI, Universidad de Antioquia, UdeA, Medellín, Colombia, South America.

ORCID-Profile: Geysson Javier Fernandez, Omar Triana-Chávez

Förderung

  • Universidad de Antioquia UdeA, SGR

Zitieren

APA

Mejía-Jaramillo, A. M., Ospina-Zapata, H., Fernandez, G. J., & Triana-Chávez, O. (2025). Transcriptomic analysis of benznidazole-resistant Trypanosoma cruzi clone reveals nitroreductase I-independent resistance mechanisms. PLOS ONE. https://doi.org/10.1371/journal.pone.0314189

Vancouver

Mejía-Jaramillo AM, Ospina-Zapata H, Fernandez GJ, Triana-Chávez O. Transcriptomic analysis of benznidazole-resistant Trypanosoma cruzi clone reveals nitroreductase I-independent resistance mechanisms. PLOS ONE. 2025. doi:10.1371/journal.pone.0314189

BibTeX
@article{MejaJaramillo2025,
  author = {Mejía-Jaramillo, Ana María and Ospina-Zapata, Hader and Fernandez, Geysson Javier and Triana-Chávez, Omar},
  title = {Transcriptomic analysis of benznidazole-resistant Trypanosoma cruzi clone reveals nitroreductase I-independent resistance mechanisms},
  journal = {PLOS ONE},
  year = {2025},
  doi = {10.1371/journal.pone.0314189}
}
Kostenlos starten →